Decision Resources Group

Our team developed an account-based marketing strategy centered on high-value content tailored to DRG’s top-priority accounts. We identified key stakeholders and mapped content to each stage of the buying journey, from thought leadership positioning DRG as a trusted intelligence partner to product-focused assets aligned with the workflows of pharmaceutical analysts. Content was designed to speak directly to a specific audience, positioning DRG’s platform as the ideal solution for high-value prospects.

We executed a coordinated multichannel campaign across email, LinkedIn, digital ads, and print to keep DRG visible throughout the buying process. Personalized outreach delivered tailored messaging to target accounts, while sponsored content and retargeting sustained engagement during evaluation. Print placements in trusted industry publications reinforced credibility with pharmaceutical strategy teams. Account-level analytics unified engagement data across channels, helping sales identify warm accounts and optimize outreach timing.

The campaign drove strong results across the funnel. Targeted email sequences achieved a 38% open rate and 12% click-through rate, engagement from priority accounts increased 64%, and inbound conversations from target companies tripled following launch. Most importantly, the campaign directly influenced seven new enterprise opportunities, increasing pipeline value by over 13% and helping position DRG’s platform as a leading intelligence solution for pharmaceutical strategy teams

Decision Resources Group (DRG) had spent months preparing the launch of a new intelligence platform built for pharmaceutical and biotech analysts driving major drug development decisions. With an established roster of leading life sciences clients, DRG already had credibility, but in a crowded market, they needed a highly targeted approach. The goal was clear: reach the right decision-makers at the right organizations with messaging that would stand out.